Frankel Stanley Insider Trades & Stock Holdings

Director · Precision Biosciences Inc · Latest filing Sep 28, 2026

Frankel Stanley, Director at Precision Biosciences Inc has 1 Form 4 trade on file since Sep 28, 2026. Open-market activity: 1 purchase ($6K) and 0 sales ($0), net +$6K. Latest filing: acquired 1K shares of $DTIL on Sep 28, 2026 at $6.

Trades on file

1

Open-market bought

$6K

Open-market sold

$0

Net open-market

+$6K

Latest filing

Sep 28, 2026

All insider trades by Frankel Stanley

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 28, 2026	$DTIL	Buy (Open-market buy)	1K	$6	$6K						Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Frankel Stanley traded

• $DTIL

Frequently asked questions

Has Frankel Stanley been buying or selling stock?

Frankel Stanley has 1 open-market purchase and 0 open-market sales on file, net +$6K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Frankel Stanley's latest insider trade?

acquired 1K shares of $DTIL on Sep 28, 2026 at $6.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.